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The discoveries of RNA interference and RNA-mediated posttranscriptional gene silencing have opened an unanticipated
new window on the regulation of gene expression as well as a facile and highly effective tool for knocking down gene
expression in many organisms and cells. In addition, RNA interference and RNA silencing may conceivably be exploited
for human therapeutics sometime in the future, possibly bringing greater clinical impact than have the so far disappoint-
ing antisense endeavors. This essay summarizes recent developments and offers some personalized perspectives, with
emphasis on what we do not yet know.
INTRODUCTION
The discovery of RNA interference (Guo and Kemphues,
1995; Fire et al., 1998) was unusual in the postmodern era of
molecular biology in that, like immunoglobulin gene rear-
rangement, for example, it was almost entirely unantici-
pated. Beyond the action of RNA interference and RNA
silencing at the translational level of gene expression, RNA-
mediated phenomena are now known to direct the tran-
scription-level silencing of some genes, and even the “edit-
ing down” of an organism’s genome by selective excision
events in certain cases (Selker, 2003; Yao et al., 2003).
In addition to possessing the element of surprise, RNA
interference and RNA silencing also explained certain pre-
vious findings that had been puzzling, and thus the discov-
eries genuinely warranted the term breakthrough. In retro-
spect, were there any clues that were missed?
Hints of RNAs That Base Pair with mRNA
In the early 1970s, intramolecular double-stranded regions
of large nuclear RNA molecules were described in both
mammalian cells and sea urchin embryos (Jelinek and Dar-
nell, 1972; Kronenberg and Humphreys, 1972; Ryskov et al.,
1972). These studies used extracted, deproteinized nuclear
RNA, but the in vivo authenticity of these double-stranded
RNA (dsRNA) regions of nuclear RNA was subsequently
verified in intact, living cells (Calvet and Pederson, 1979).
An intriguing finding was that although cytoplasmic mRNA
did not contain these intramolecular dsRNA regions, the
dsRNA elements of nuclear RNA could nevertheless hybrid-
ize with cytoplasmic mRNA (Stampfer et al., 1972; Naora
and Whitelam, 1975; Ryskov et al., 1976; Jelinek et al., 1978).
The implication was that a portion of a given nuclear dsRNA
region is conserved in mRNA with the remainder of the
dsRNA region being eliminated, i.e., the nuclear dsRNA-
containing molecules are mRNA precursors. But alterna-
tively, if a dsRNA-containing nuclear RNA molecule pro-
duced a small RNA that ended up hydrogen-bonded to a
complementary stretch in a (separately encoded and gener-
ated) cytoplasmic mRNA, as in the RNA silencing of mRNA
that has now been discovered, the observations would have
been the same as the ones made.
The idea that intermolecular RNA–RNA interactions were
involved in gene regulation was also advanced on the basis
of other studies (Britten and Davidson, 1969), and later
experiments revealed that duplex regions form between
HeLa cell heterogeneous nuclear RNA molecules when an-
nealed under certain conditions (Fedoroff et al., 1977). Dur-
ing the same period, there were numerous reports of small,
translation-suppressing RNAs associated with inactive mes-
senger ribonucleoproteins, called translation control RNAs
(tcRNAs). In some experiments, these small tcRNAs be-
haved as if hydrogen bonded to the inactive mRNA (Hey-
wood and Kennedy, 1976). The tcRNA work never really
caught on at the time, but of course now seems provocative
in retrospect.
Pre-microRNAs in the Genome
The endogenous pathway of mRNA silencing involves small
RNAs, called microRNAs (abbreviated miRNAs) that are
encoded in the organism’s genome and expressed in the
appropriate developmental schedule (Moss, 2002; Pas-
quinelli, 2002). miRNAs are derived from larger precursor
molecules in the nucleus, the most proximal of which are
70-nt molecules consisting of imperfectly paired hairpins
(Lee et al., 2002, 2003; Seitz et al., 2003) Very little is known
about how these “pre-miRNAs” are themselves produced
but the available data are compatible with the derivation of
the 70-nt pre-miRNAs from considerably longer nuclear
transcripts that lack translation open reading frames. It is
interesting to recall in this respect that early studies on
mammalian nuclear RNA revealed that a substantial portion
of large, poly(A)-terminated molecules do not contain any
sequences homologous to mRNA (Herman et al., 1976;
Salditt-Georgieff et al., 1981). The functional significance of
this puzzling population of nuclear RNA has remained elu-
sive for a quarter of a century. Plausibly, it might harbor
precursors of the pre-miRNAs, i.e., the “pre-pre-miRNAs.”
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The initial studies of the intramolecular RNA duplex frac-
tion of heterogeneous nuclear RNA (hnRNA) in HeLa cells
operatively defined these regions by their resistance to
RNases A and T1 (Jelinek and Darnell, 1972; Kronenberg
and Humphreys, 1972; Ryskov et al., 1972; Calvet and Ped-
erson, 1977; 1978) or RNases A and T2 (Roberston et al., 1977;
Jelinek, 1977). One of these investigations scrutinized these
double-stranded regions in particular detail, based on their
relative resistance to single-strand–specific versus double-
strand–specific conditions of RNase attack, and identified
two distinct classes of dsRNA within hnRNA, one more
perfectly base paired than the other (Calvet and Pederson,
1977). The pre-micro RNAs identified so far are 70-nt
RNAs with some base-pairing mismatches (Lagos-Quintana
et al., 2001; Lau et al., 2001; Lee and Ambros, 2001; Moure-
latos et al., 2002). It is not possible at present to relate these
identified nuclear pre-miRNAs to the previously character-
ized dsRNA regions of hnRNA, but this is a high priority for
understanding the biosynthesis of the miRNAs. In addition,
there are other sequence families in mammalian genomes
(Alu sequences in human) that produce, mostly via tran-
scription by RNA polymerase III, small RNAs that contain
stem-loop domains very similar to ones in the presently
defined pre-miRNAs. Unfortunately, nothing else is pres-
ently known about the primary transcripts that give rise to
pre-miRNAs, including the particular RNA polymerase that
makes them (presumably pol II). A recent study demon-
strated that a human pre-miRNA contains a 5-phosphate, a
3-OH, and a 1-4 nt 3 overhang, consistent with an RNase
III-mediated derivation (Basyuk et al., 2003).
Is RNA Interference Restricted to mRNA Targets?
What is the target “reach” of RNA interference and mRNA
silencing? Until recently, all the demonstrated RNA inter-
ference targets were messenger RNAs. For example, a recent
study has demonstrated that certain endogenous small in-
terfering RNA (siRNA)-like RNAs in the protozoan Trypano-
soma brucei are complexed with polyribosomes in a manner
that is dependent on active translation (Djikeng et al., 2003).
The extant reports using siRNAs to knock down RNA viral
replication, a situation in which there are RNA species other
than translating mRNA as potential targets, are almost cer-
tainly due to action on viral mRNAs (Dector et al., 2002;
Jacque et al., 2002; Ge et al., 2003; McCaffrey et al., 2003;
Novina et al., 2003). Reports that translationally repressed,
maternal mRNAs become susceptible to RNA interference
only upon their developmental translational activation (Svo-
boda et al., 2000; Kennerdell et al., 2002) have fueled the idea
of a direct connection between RNAi or mRNA silencing
and the target’s active translational status. So, is there any
basis for considering RNA interference or mRNA silencing
more broadly than only targeting translating mRNAs?
At first, the most plausible initial interpretation of the
discovery of RNA interference was the one deriving from an
evolutionary perspective, namely, that of an ancient defense
against RNA genome-based infectious or parasitic organ-
isms, a defense retained in extant organisms, but one that
has also been tinkered with and tooled over 2.5 billion
years into a developmental gene regulation pathway in the
metazoan Eukarya (Zamore, 2002). Such a mechanism
would have likely first operated on an mRNA encoded (or
brought in as genomic RNA) by a RNA virus. This idea
sounds very plausible on evolutionary grounds. As for
mRNA silencing by small RNAs, there is ample precedent in
prokaryotes so perhaps this was an early feature of gene
regulation that evolved before, or at least independently of,
double-stranded RNA-triggered mechanisms.
RNAi Hits non-mRNA
The idea that the action of RNAi is restricted to translating
mRNAs was perhaps not ever assumed by the field’s lead-
ers, but it is certainly the prevailing operative view of most
cell biologists using siRNAs to knockdown target mRNAs.
By way of an example, in a recent collaborative study of
mine in this journal (Wang et al., 2003), the use of siRNA to
knock down a relevant mRNA in a mammalian cell line
worked beautifully, as is very typical, but the more unor-
thodox possibility of using siRNA to knock down the small,
RNA polymerase III transcripts that were of even greater
interest in the study was not pursued.
The notion that siRNA targets must be mRNAs has re-
cently been dramatically overturned (Liang et al., 2003).
Ironically, one of the (three) organisms in which this study
was done was the very same one in which the aforemen-
tioned link of RNAi action to translating mRNA was re-
ported, namely, T. brucei, one of the first organisms in which
RNA interference was described (Ngo et al., 1998). These
investigators decided to target a group of small nucleolar
RNAs (snoRNAs) that play a role in the biosynthesis of
rRNA in the nucleolus (Bachellerie et al., 2002). They ex-
pressed siRNAs complementary to these snoRNAs and ob-
served their destruction (Liang et al., 2003). This study is the
first to demonstrate that siRNA can attack a nonpolysomal,
non-mRNA target and in a cellular compartment other than
the cytoplasm, the nucleus. Moreover, the target RNAs in
this study have 5 termini different than mRNA and also
lack 3 poly(A) tails, ruling out these ends of RNA as being
required for siRNA action.
Can knocking down (or out) non-mRNA “housekeeping”
RNAs, such as snoRNAs, be anything beyond just a good
learning curve for understanding the molecular biology of
cells? Consider a protein called Ro. It is a human autoanti-
gen that is complexed with a group of small, cytoplasmic
non-mRNAs in higher animals (Tan, 1982). When the gene
for the Ro protein was knocked out of mice (by transgenic,
heritable means, not transiently by RNA interference), the
animals displayed phenotypes (Xue et al., 2003) that have the
potential to contribute, with further work, to advances in
our understanding of two of the most challenging and im-
portant current problems in all of medicine: innate immu-
nity and immunological tolerance. Knockdown of the
mRNA for Ro protein, or of the Ro RNAs themselves, by
siRNA in mammalian cells or animals might offer additional
experimental dimensions, now empowered by the trans-
genic knockout results. There are many other non-mRNAs
of unknown function in eukaryotic cells, and it is possible
that they too can be approached by RNA interference. Some
of these may themselves turn out to be elements of RNA-
mediated gene regulation. For example, can siRNAs knock
down miRNAs?
The scale of RNA interference-mediated analysis of gene
expression has now reached breathtaking levels in ideal
organisms. In the first two large-scale applications of this
approach, the mRNAs from 5000 genes in Caenorhabditis
elegans were systematically deleted, and more recently sev-
eral studies of nearly comparable scale have been carried out
in Drosophila cells (Pollard, 2003). Microarray-based ap-
proaches to the discovery of novel microRNAs are also now
coming onto the scene (Krichevsky et al., 2003), so our un-
derstanding of the endogenous pathways of mRNA silenc-
ing and related miRNA functions, i.e., establishment of het-
erochromatin or genome reorganization, can be anticipated
to rapidly expand during 2004.
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Envisioning the Patient
Major questions remain about the utility of these discoveries
for medicine, including the pharmacokinetics of adminis-
tered siRNAs, the challenges of gene therapy-based ap-
proaches to implanting an intracellular supply of a miRNA
in patients, and, most sobering of all, the implausibility of
mRNA knockdown approaches for conditions based on loss
of function mutations. Also to be borne in mind is the
possibility that initially seductive mRNA targets revealed by
microarray analysis may turn out not to be at the true center
of the pathogenic process in the case of noninfectious dis-
ease (as opposed to the more immediately promising viral
disease opportunities for siRNAs.) There is also the question
of whether knockdown of a desired target, perhaps to the
good, might bring with it an undesired shutdown of certain
other, essential mRNAs in response, due to the operation of
feedback controls that sense the targeted mRNA’s presence
or activity. These questions surrounding the utility of these
discoveries for medicine (or agriculture) do not, of course,
diminish the deserved excitement about the discoveries of
RNA interference and RNA silencing as science. This essay
has endeavored to add at least a small degree of perspective
to this explosively emerging field. It seems likely that there
is much more biology to be uncovered, and it is possible that
major applications in medicine and agriculture may ensue,
driven by the reliable engine of basic research.
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